31 August - 04 September 2019, Paris - France

Session Details

Poster Session 4: Secondary hypertension and genes
Mon 02 Sep 08:30 - 12:30 European Society of Cardiology Poster Session, Abstract-based Programme Posters - Poster Area
Learning Objectives: Posters are on display from 08:30 – 12:30. Presenters will be by their poster during the coffee break from 10:05 and 10:55 for posters viewing time.

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
08:30P3560Prospects for the use of integrated assessment of gene-candidates polymorphisms in the management of arterial hypertension: let's start.Vadym BONDAR (Odessa, Ukraine)
08:30P3561Detection and functional characterization of angiotensin receptor type 1 autoantibodies: establishment and clinical translationValerie BOIVIN (Wuerzburg, Germany)
08:30P3562Efficient selection of patients with aldosterone-producing adenoma using the ACTH stimulation testToshihiro KITA (, Japan)
08:30P3563The influence of circadian patterand obstructive sleep apnean of blood pressure in nocturnal arrhythmias in hypertensive patientsPedro AMADOR (Setubal, Portugal)
08:30P3564Percutaneous intervention with stent improves blood pressure and renal function in patients with transplanted renal artery stenosisAttilio GALHARDO (Sao Paulo, Brazil)
08:30P3566Ambulatory blood pressure response to riboflavin supplementation in adults with the C677T polymorphism in the folate metabolising enzyme methylenetetrahydrofolate reductase (MTHFR)Mary WARD (Coleraine, United Kingdom of Great Britain & Northern Ireland)
08:30P3567Genetic screening for monogenic hypertension in hypertensive individuals in a clinical settingMinghui BAO (Beijing, China)
08:30P3568The relationship between plasma renin and aldosterone levels and the reduction of blood pressure with spironolactone in patients with resistant hypertension.Oksana OBERTYNSKA (Vinnytsia, Ukraine)
08:30P3569The effect of percutaneous renal revascularization upon cardiac structure and function in patients with significant atherosclerotic renal artery stenosisDana Oliviana GEAVLETE (Bucharest, Romania)
08:30P3570Bilateral renal artery stenting is effective method for the treatment of uncontrolled hypertension and renal functionJamol UZOKOV (Tashkent, Uzbekistan)
08:30P3571Genes polymorphism and renal dysfunction formation in arterial hypertension patients with high adherence to treatmentNatalia KOZIOLOVA (Perm, Russian Federation)
08:30P3573Different contribution of sympathetic nerve activity to pulse wave velocity and arterial velocity pulse index in healthy subjects.Hiroyuki SUGIMOTO (Toyama, Japan)
08:30P3574Association of the plasma aldosterone, arterial stiffness and left atrium volume index in hypertensive patients Elena SHAVAROVA (Moscow, Russian Federation)